PharmaNews.eu
Breaking World Pharma News
AstraZeneca's revenue in the fourth quarter was unchanged at CER and on an actual basis as exchange rate movements were neutral to reported revenue. Adjusted for the disposal of Astra Tech, revenue growth was 2 percent.
Pfizer Inc. (NYSE: PFE) reported financial results for fourth-quarter and full-year 2011. Fourth-quarter 2011 revenues were $16.7 billion, a decrease of 4% compared with $17.4 billion in the year-ago quarter, which reflects an operational decline of $765 million, or 5%, and the favorable impact of foreign exchange of $157 million, or 1%.
Novartis will continue its work with the World Health Organization (WHO) toward a world free of leprosy by extending its drug donation of multidrug therapy (MDT) medicines to treat leprosy through the year 2020.
Amgen (NASDAQ: AMGN) reported total revenue increased 3 percent during the fourth quarter of 2011 to $3,973 million versus $3,841 million in the fourth quarter of 2010. For the full year 2011, total revenue increased 4 percent to $15,582 million from $15,053 million in 2010.
Most Read News
- AstraZeneca and IMS Health announce real-world evidence collaboration in Europe
- Bristol-Myers Squibb to Acquire Inhibitex
- Novartis to restructure US business to strengthen competitive position
- New 'smart' nanotherapeutics can deliver drugs directly to the pancreas
- Bayer HealthCare to Share Lab Space with Start-Up Companies
- Chemotherapy may influence leukemia relapse
- Rising Interest of Big Pharma Creates Immense Growth Potential for Contract Manufacturing Organisations
Company Profiles and News
Showcase your Company Profile / News
Pharmaceutical Companies
News in Pictures
Be on top of World Pharma News!
Advertise with us - Download World Pharma News' Media Pack Read more
Abbott Launches New Psoriasisanswers.com Web site
August marks National Psoriasis Awareness Month, an opportunity to raise awareness about psoriasis, a skin disease that affects nearly 7.5 million Americans. For those living with this condition, finding information Read more
AstraZeneca Headquarters, London
AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialisation of prescription medicines. As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, Read more
Site Roche Basel
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in Read more
Gehry building, Novartis headquarters in Basel, Switzerland
Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving Read more
GSK Corporate HQ
GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better Read more
Sanofi-aventis Group head office
Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: Read more
Boehringer Ingelheim Center, Ingelheim, Germany
The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 142 affiliates in 50 countries and more than 41,500 Read more
Novo Nordisk's corporate headquarters in Bagsværd, Denmark
Headquartered in Denmark, Novo Nordisk is a global healthcare company with 87 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth Read more
Sponsored Links
Business & Industry News
- AstraZeneca fourth quarter and full year results 2011
- Pfizer reports fourth-quarter and full-year 2011 results
- Novartis extends commitment to help achieve final elimination of leprosy
- Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion
- Alzheimer's Challenge 2012: seeking new tools to help improve Alzheimer's care
- Bristol-Myers Squibb delivers solid fourth quarter capping a year highlighted by new product approvals
- Amgen to Acquire Micromet
Research & Development News
- Websites advertising cholesterol-lowering drugs of poor quality
- Protein structures give disease clues
- Rising Interest of Big Pharma Creates Immense Growth Potential for Contract Manufacturing Organisations
- Sweeping genetic analysis of rare disease yields common mechanism of hypertension
- 'Pulverized' chromosomes linked to cancer?
- Continuing uncertainties surround anti-influenza drug
- New drug screening identifies chemical agents with potent anti-cancer activity
Conferences & Events News
- 3rd Mastering HR Summit 2012
- ePatient / Health 2.0 - A Key Factor for New and Innovative Business Models for the Life Sciences Industry
- Global E-Health Forum - Hamburg 2011
- Health 2.0 Europe: Over 35 Speakers from 15 Countries Already Confirmed
- 2nd Mastering HR Summit 2011
- Health 2.0 Europe 2011 - Registration is Now Open
- Global E-Health Forum: Designing Personalized Healthcare